Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Given that establishing biological efficacy is the primary objective of the trial, according to the pre-specified estimand, all participants who achieve at least 80% study medication compliance and provide a 180-day blood sample will be included in the primary efficacy analysis
Transglutaminase 2 expression predicts progression free survival in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor
HIV-1 protease cleaves the nascent proteins into their functional form
Available at: www.ipledgeprogram.com
US$ 25.43
US$ 25.08
US$ 24.22
US$ 27.13
US$ 28.51
US$ 26.36
US$ 26.59
US$ 25.79
US$ 20.25
US$ 29.00
